Wave Life Sciences Ltd. - WVE STOCK NEWS

IMPACT

SENTIMENT

12/23/2021 07:06 PM

VWE : Nasdaq WVE : Nasdaq

Vintage Wine Estates marks eight years and one million meals donated through its Angels Share campaign to fight food insecurity

IMPACT

SENTIMENT

11/10/2021 07:30 AM

WVE : Nasdaq

Wave Life Sciences Reports Third Quarter 2021 Financial Results and Provides Business Update

IMPACT

SENTIMENT

11/08/2021 04:05 PM

WVE : Nasdaq

Wave Life Sciences to Present at the Stifel 2021 Virtual Healthcare Conference

IMPACT

SENTIMENT

11/01/2021 08:30 AM

WVE : Nasdaq

Wave Life Sciences to Webcast Conference Call of Third Quarter 2021 Financial Results on November 10, 2021

IMPACT

SENTIMENT

10/18/2021 05:00 PM

WVE : Nasdaq

Wave Life Sciences and Takeda Amend CNS Collaboration

IMPACT

SENTIMENT

09/29/2021 08:30 AM

WVE : Nasdaq

Wave Life Sciences Announces Initiation of Dosing in Phase 1b/2a Clinical Trial of WVE-N531 in Duchenne Muscular Dystrophy

IMPACT

SENTIMENT

09/28/2021 04:05 PM

WVE : Nasdaq

Wave Life Sciences Announces New Data for Leading RNA Editing Capability Across Multiple Tissues and Provides Update on AATD Program During Analyst and Investor Research Webcast

IMPACT

SENTIMENT

09/22/2021 04:05 PM

WVE : Nasdaq

Wave Life Sciences to Present at the Chardan Virtual Genetic Medicines Conference

IMPACT

SENTIMENT

09/09/2021 08:30 AM

WVE : Nasdaq

Wave Life Sciences Announces Initiation of Dosing in Phase 1b/2a SELECT-HD Clinical Trial of WVE-003 in Huntington’s Disease

IMPACT

SENTIMENT

09/08/2021 08:30 AM

WVE : Nasdaq

Wave Life Sciences to Highlight RNA Editing Capability and AATD and Neurology Programs at 2021 Analyst and Investor Research Webcast on September 28, 2021

Wave Life Sciences Ltd.

Nasdaq:WVE

WVE Rankings

#3558 Ranked by Market Cap

N/A Ranked by Dividends

WVE Stock Data

Industry Pharmaceutical Preparation Manufacturing

Sector Manufacturing

Website Link

Country Singapore

City 7 Straits View

About WVE

wave life sciences ltd. (nasdaq: wve) is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, delivering new treatment options for patients. given the unique versatility of its chemistry platform, wave’s pipeline spans multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded rnai.